TREDEGAR CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TREDEGAR CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	828	961
Cost of revenue	660	768	680	641	559	650
Gross profit	168	194
Research and development	19.1	18.3	6.67	7.89	8.4	6.35	5.32	2.89	0.71	0.7
Selling, general and administrative	73.5	83.4	67.9	76.6	84.2	75	69.6	65.4	73	79
Interest expense	3.81	6.17	5.7	4.05	2.59	3.39	4.14	6.32	4.66	4
Interest income	0.26	0.21	0.15	0.07	0.04	0.07	0.02	0.51	0.04	0.04
Other non-operating income	-2.38	-51.7	-30.5	-28.4	67.3	-20.3	-1.06	2.15	0.95	-1.4
Pre-tax income	27.7	-14.9	80.4	72	-25	67.1	9.56	-150	0.88	30.7
Income tax	3.22	-53.2	18.8	13.5	-8.21	9.28	-3.02	-51.3	-0.17	6.58
Income from continuing operations	24.5		61.6	58.5	-16.8	57.9	12.6	-99.2	1.05	24.1
Net income	24.5	38.3	24.8	48.3	-75.4	57.8	28.5	-106	-64.6	33.5
EPS, basic	0.75	1.16	0.75	1.45	-2.26	1.72	0.84	-3.10	-1.88	0.96
EPS, diluted	0.75	1.16	0.75	1.45	-2.26	1.72	0.84	-3.10	-1.88	0.96
Shares, basic (weighted)	32.8	32.9	33.1	33.2	33.4	33.6	33.8	34.1	34.3	34.7
Shares, diluted (weighted)	32.8	33	33.1	33.3	33.4	33.7	33.8	34.1	34.3	34.7
Dividend per share	0.44	0.44	0.44	0.46	6.45	0.48	0.50	0.26

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	29.5	36.5	34.4	31.4	11.8	30.5	19.2	9.66	7.06	6.73
Receivables	91.1	123	128	91	89.1	105	87.5	56.8	65	82.1
Inventory	66.1	86.9	93.8	64.2	66.4	88.6	128	49.7	51.4	65
Other current assets	7.74	8.22	9.56	8.33	19.7	11.3	10.3	8.82	16.6	15.5
Total current assets	208	284	269	233	188	236	243	177	140	169
Property, plant and equipment	261	223	228	174	167	170	186	151	137	133
Lease right-of-use assets			0	18.5	16	13.8	14	11.1	14.6	12.8
Goodwill	118	128	81.4	81.4	67.7	70.6	70.6	35.7	22.4	22.4
Intangible assets	33.6	40.6	36.3	22.6	18.8	14.2	11.7	9.11	7.33	5.57
Other non-current assets	10	9.42	4.01	4.63	3.51	2.46	2.88	3.44	2.45	2.27
Total assets	651	756	707	713	515	524	542	446	356	371
Accounts payable	81.3	108	113	87.3	89.7	124	115	69.3	64.7	75.8
Accrued liabilities	38.6	42.4	42.5	39.5	40.7	33.1	31.6	18.6	22.2	25.4
Short-term debt							0	126	1.32	0.5
Total current liabilities	120	151	155	152	141	169	150	249	91.7	104
Long-term debt	95	152	102	42	134	73	137	0	60.6	34.6
Lease liabilities				17.3	14.9	12.8	12.7	10.4	13	11
Other non-current liabilities	8.91	8.18	7.64	5.3	5.53	6.22	5.83	3.86	4.11	3.73
Total liabilities	340	412	353	336	406	339	340	291	175	155
Total debt	95	152	102	42	134	73	137	0	60.6	34.6
Retained earnings	464	487	498	530	239	281	293	178	113	147
Other comprehensive income	-183	-177	-180	-198	-178	-150
Shareholders' equity	311	344	355	377	109	185	202	156	181	217
Total equity	311	344	355	377	109	185	202	156	181	217
Total liabilities and equity	651	756	707	713	515	524	542	446	356	371
Shares outstanding	32.9	33	33.2	33.4	33.5	33.7	34	34.4	34.7	34.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	24.5	38.3	24.8	48.3	-75.4	57.8	28.5	-106	-64.6	33.5
Depreciation and amortization	32.5	40.3	33.8	44.3	32	23.8	26.4	25.8	23.7	20
Stock-based compensation				1.3	0.1
Deferred income tax	-3.63	-36.7	17.2	3.86	-15.5	-6.23	-3.72	-11.6	-0.89	6.18
Change in inventory	1.13	-9.13	-9.58	11.3	-4.37	-23.1	-37.8	47.6	-6.91	-13.6
Change in payables	0.16	21.1	5.57	-2.94	4.05	19.8	-14.9	-25.2	10	13.6
Cash from operations	48.9	88.2	97.8	116	74.4	70.6	-20.8	24	25.5	33
Capital expenditures	-45.5	-44.4	-40.8	-50.9	-23.4	-27.4	-36.9	-26.4	-14.3	-17.2
Acquisitions	0	-87.1	0	0
Cash from investing	-42	-126	-34.1	-39.9	32.9	24.5	-35.5	-26.2	40.5	-5.5
Share buybacks		-0.12	0.33	0.85
Dividends paid	-14.5	-14.5	-14.6	-15.3	-216	-16.2	-17	-8.88	0	0
Cash from financing	-23.7	43.2	-64.1	-77.3	-126	-76.8	45.4	-4.48	-65	-28.2
Exchange rate effect	2.23	1.21	-1.72	-1.6	-1.24	0.48	-0.37	0.9	-7.44	0.35
Net change in cash	-14.6	6.98	-2.09	-2.98	-19.6	18.7	-11.3	-5.78	-6.39	-0.33
Free cash flow	3.42	43.9	57	65	51	43.2	-57.7	-2.45	11.2	15.7
Interest paid	3.07	5.81	5.42	4.36	1.68	2.92	4.42	10.5	13.5	3.9
Income taxes paid	15.4	9.19	-24	2.6	1.67	4.71	10.8	2.28	12.2	3.36

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $7.05 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Effective tax rate	19.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.1%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Net income CAGR, 3y	5.6%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 3y	4.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	29.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	-15.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	41.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-21.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	19.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-11.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-6.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.73x	Current assets / current liabilities.
Quick ratio	0.95x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.20x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	11.1%	Total debt / total assets.
Liabilities / assets	44.6%	Total liabilities / total assets.
Net debt	$28.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$88.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	6.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$201.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
FCF conversion	67.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	48.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.96	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share	$0.65	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.25	Cash from operations / diluted weighted shares.
Book value per share	$6.54	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.77	Tangible book value / shares outstanding.
Cash per share	$0.49	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$246.4M	Share price x shares outstanding.
Enterprise value	$275.2M	Market cap + total debt - cash - short-term investments.
P/E	7.39x	Market cap / net income. Only when net income is positive.
P/B	1.08x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.22x	Market cap / tangible book value, when positive.
P/FCF	10.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.66x	Market cap / cash from operations, when positive.
EV/FCF	12.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.2%	Free cash flow / market cap.
Earnings yield	13.5%	Net income / market cap (the inverse of P/E).
PEG	1.62x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

Was TREDEGAR CORP profitable in fiscal 2025?

Yes. Net income was $33.5M, a net margin of -.

How much free cash flow did TREDEGAR CORP generate in fiscal 2025?

Cash from operations of $33.0M minus capital expenditures of $17.2M left free cash flow of $15.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TREDEGAR CORP